The medical second opinion market was valued at US$ 3,204.57 million in 2019 and is projected to reach US$ 10,739.48 million by 2027; it is expected to grow at a CAGR of 16.32% during 2020-2028. The growth of the medical second opinion market is mainly attributed to the increasing prevalence of chronic diseases, growing emphasis on superior treatment outcomes, and rising focus on healthcare cost optimization. However, the lack of awareness and reluctance toward opting for medical second opinions in emerging nations restrains the growth of the market.
Increasing emphasis on achieving better treatment outcomes drives the growth of the second medical opinion market. Many treatment procedures are known he have high possibility to be associated with adverse effects, which might as well lead to mortality. Hence, in crucial cases, revising the current treatment alternatives and getting advice from another reliable healthcare professional to avoid possible ill-effects becomes essential. According to a study published by the World Health Organization (WHO) in 2019, unsafe medical care causes ~2.6 million deaths each year in the low- and middle-income countries. Such large extent of lethality is anticipated to encourage consumers to opt for medical second opinion. According to a study published by the John Hopkins University, in 2018, in the US, ~250,000 deaths are caused due to medical errors each year.
According to a study published in Annals of Surgical Oncology in 2018, there is great emphasis on getting medical second opinion to increase the accuracy of cancer diagnosis and therapeutics. According to the WHO data, in 2018, ~9.6 million patients across the globe lost their lives due to the occurrence of cancer. In addition, the growing exposure to risk factors such as consumption of tobacco, excessive alcoholism, unhealthy diet, and obesity is further projected to elevate the prevalence of cancer. Thus, an increasing prevalence of cancer, combined with more number of cancer patients seeking for second opinion, would be a prominent factor to drive the growth of the medical second opinion market during the forecast period.
Based on disorders, the medical second opinion market is segmented into cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematologic blood disorders, chronic obstructive pulmonary disease (COPD), organ transplant, and other diseases. The cancer segment held the largest share of the market in 2019. However, the market for orthopedic conditions is estimated grow at the highest CAGR in the market during the forecast period.
Based on service provider, the market is segmented into hospitals, health insurance companies, and online services. The hospitals segment held the largest share of the market in 2019; however, online services segment is estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), National Health Service (NHS), Health Blogs, and Centers for Disease Control and Prevention (CDC), along with company websites, are a few of the major primary and secondary sources referred for preparing this report.
Reasons to Buy
Increasing emphasis on achieving better treatment outcomes drives the growth of the second medical opinion market. Many treatment procedures are known he have high possibility to be associated with adverse effects, which might as well lead to mortality. Hence, in crucial cases, revising the current treatment alternatives and getting advice from another reliable healthcare professional to avoid possible ill-effects becomes essential. According to a study published by the World Health Organization (WHO) in 2019, unsafe medical care causes ~2.6 million deaths each year in the low- and middle-income countries. Such large extent of lethality is anticipated to encourage consumers to opt for medical second opinion. According to a study published by the John Hopkins University, in 2018, in the US, ~250,000 deaths are caused due to medical errors each year.
According to a study published in Annals of Surgical Oncology in 2018, there is great emphasis on getting medical second opinion to increase the accuracy of cancer diagnosis and therapeutics. According to the WHO data, in 2018, ~9.6 million patients across the globe lost their lives due to the occurrence of cancer. In addition, the growing exposure to risk factors such as consumption of tobacco, excessive alcoholism, unhealthy diet, and obesity is further projected to elevate the prevalence of cancer. Thus, an increasing prevalence of cancer, combined with more number of cancer patients seeking for second opinion, would be a prominent factor to drive the growth of the medical second opinion market during the forecast period.
Based on disorders, the medical second opinion market is segmented into cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematologic blood disorders, chronic obstructive pulmonary disease (COPD), organ transplant, and other diseases. The cancer segment held the largest share of the market in 2019. However, the market for orthopedic conditions is estimated grow at the highest CAGR in the market during the forecast period.
Based on service provider, the market is segmented into hospitals, health insurance companies, and online services. The hospitals segment held the largest share of the market in 2019; however, online services segment is estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), National Health Service (NHS), Health Blogs, and Centers for Disease Control and Prevention (CDC), along with company websites, are a few of the major primary and secondary sources referred for preparing this report.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the medical second opinion market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global medical second opinion market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Medical Second Opinion Market- By Disorder
1.3.2 Global Medical Second Opinion Market- By Service Provider
1.3.3 Global Medical Second Opinion Market- By Geography
2. Medical Second Opinion Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Medical Second Opinion Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinion
5. Medical Second Opinion Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Emphasis on Superior Treatment Outcomes
5.1.2 Increasing Preference for Healthcare Cost Optimization
5.2 Key Market Restraints
5.2.1 Lack of Awareness and Reluctance toward Opting for Medical Second Opinion in Emerging Nations
5.3 Key Market Opportunities
5.3.1 Rising Investments on Telemedicine Technologies
5.4 Future Trends
5.4.1 Digitalization of Medical Consulting Services
5.5 Impact Analysis
6. Medical Second Opinion Market- Global Analysis
6.1 Global Medical Second Opinion Market Revenue Forecast And Analysis
6.2 Global Medical Second Opinion Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Medical Second Opinion Analysis - By Disorders
7.1 Overview
7.2 Medical Second Opinion Market Share, by Disorder, 2019 and 2027 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Medical Second Opinion Market- Revenue and Forecast to 2027 (US$ Million)
7.4 COPD (Chronic Obstructive Pulmonary Disease)
7.4.1 Overview
7.4.2 COPD: Medical Second Opinion Market- Revenue and Forecast to 2027 (US$ Million)
7.5 Cardiac Disorders
7.5.1 Overview
7.5.2 Cardiac Disorders: Medical Second Opinion Market- Revenue and Forecast to 2027 (US$ Million)
7.6 Neurological disorders
7.6.1 Overview
7.6.2 Neurological Disorders: Medical Second Opinion Market- Revenue and Forecast to 2027 (US$ Million)
7.7 Nephrological Disorders
7.7.1 Overview
7.7.2 Nephrological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Hematologic Blood Disorders
7.8.1 Overview
7.8.2 Haematological Blood Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
7.9 Orthopaedic Disorders
7.9.1 Overview
7.9.2 Orthopaedic Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
7.10 Organ Transplant
7.10.1 Overview
7.10.2 Organ Transplant: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
7.11 Other Disorders
7.11.1 Overview
7.11.2 Other Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
8. Medical Second Opinion Market Analysis - By Service Providers
8.1 Overview
8.2 Medical Second Opinion Market Share, by Service Provider, 2019 and 2027, (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Health Insurance Companies
8.4.1 Overview
8.4.2 Health Insurance Companies: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Online Services
8.5.1 Overview
8.5.2 Online Services: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
9. Medical Second Opinion Market - Geographic Analysis
9.1 North America: Medical Second Opinion Market
9.1.1 Overview
9.1.2 North America: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Medical Second Opinion Market, by Disorders, 2018-2027 (USD Million)
9.1.4 North America: Medical Second Opinion Market, by Service Provider, 2018-2027 (USD Million)
9.1.5 North America: Medical Second Opinion Market, by Country, 2019& 2027 (%)
9.1.5.1 US: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.1.1 US: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.1.2 US: Medical Second Opinion Market, by Disorder, 2018-2027 (USD Million)
9.1.5.1.3 US: Medical Second Opinion Market, by Service Provider, 2018-2027 (USD Million)
9.1.5.2 Canada: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.1 Canada: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.2 Canada: Medical Second Opinion Market, by Disorder, 2018-2027 (USD Million)
9.1.5.2.3 Canada: Medical Second Opinion Market, by Service Provider 2018-2027 (USD Million)
9.1.5.3 Mexico: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.3.1 Mexico: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.3.2 Mexico: Medical Second Opinion Market, by Disorder, 2018-2027 (USD Million)
9.1.5.3.3 Mexico: Medical Second Opinion Market, by Service Provider, 2018-2027 (USD Million)
9.2 Europe: Medical Second Opinion Market
9.2.1 Overview
9.2.2 Europe: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
9.2.5 Europe: Medical Second Opinion Market, by Country, 2019 & 2027 (%)
9.2.5.1 Germany: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.1.1 Germany: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.1.2 Germany Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.2.5.1.3 Germany Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.2.5.2 UK: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.2.1 UK: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.2.2 UK Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.2.5.2.3 UK Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.2.5.3 France: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.3.1 France: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.3.2 France Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.2.5.3.3 France Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.2.5.4 Spain: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.4.1 Spain: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.4.2 Spain Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.2.5.4.3 Spain Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.2.5.5 Italy: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.5.1 Italy: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.2.5.5.2 Italy Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.2.5.5.3 Italy Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.3 Asia Pacific: Medical Second Opinion Market
9.3.1 Overview
9.3.2 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.3.4 Asia Pacific Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
9.3.5 Asia Pacific: Medical Second Opinion Market, by Country, 2019 & 2027 (%)
9.3.5.1 China: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.1.1 China: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.1.2 China Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.3.5.1.3 China Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.3.5.2 Japan: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.2.1 Japan: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.2.2 Japan Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.3.5.2.3 Japan Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.3.5.3 India: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.3.1 India: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.3.2 India Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.3.5.3.3 India Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.3.5.4 South Korea: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.4.1 South Korea: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.4.2 South Korea Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.3.5.4.3 South Korea Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.3.5.5 Australia: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.5.1 Australia: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.5.2 Australia Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.3.5.5.3 Australia Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.4 Middle East & Africa: Medical Second Opinion Market
9.4.1 Overview
9.4.2 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
9.4.3 Middle East & Africa Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East & Africa Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East & Africa: Medical Second Opinion Market, by Country, 2018 & 2027 (%)
9.4.5.1 UAE: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.4.5.1.1 UAE: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.4.5.1.2 UAE Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.4.5.1.3 UAE Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.4.5.2 Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.4.5.2.1 Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.4.5.2.2 Saudi Arabia Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.4.5.2.3 Saudi Arabia Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.4.5.3 South Africa: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.4.5.3.1 South Africa: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.4.5.3.2 South Africa Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.4.5.3.3 South Africa Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Medical Second Opinion Market
9.5.1 Overview
9.5.2 South and Central America: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.5.5 South and Central America: Medical Second Opinion Market, by Country, 2019 & 2027 (%)
9.5.5.1 Brazil: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.5.5.1.1 Brazil: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.5.5.1.2 Brazil Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.5.5.1.3 Brazil Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
9.5.5.2 Argentina: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.5.5.2.1 Argentina: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
9.5.5.2.2 Argentina Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
9.5.5.2.3 Argentina Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
10. Impact of COVID-19 Pandemic on Global Medical Second Opinion Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Medical Second Opinion Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Medical Second Opinion Market, 2015-2021
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Medisense Healthcare Solutions Pvt. Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Second Opinion International
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Elite Medical Services
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cigna
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Helsana
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 WorldCare
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Vidal Health Insurance TPA Pvt Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Medix
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 2nd.MD (Innovation Specialists LLC)
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 SWOT Analysis
12.9.5 Key Developments
12.10 AXA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Teladoc Health, Inc.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 DoctorSpring Pvt. Ltd
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 USARAD Holdings Inc (SecondOpinions.com)
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Cleveland Clinic
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Grand Rounds, Inc.
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 Mass General Brigham Incorporated. (Partners Healthcare)
12.16.1 Key Facts
12.16.2 Business Description
12.16.3 Products and Services
12.16.4 Financial Overview
12.16.5 SWOT Analysis
12.16.6 Key Developments
12.17 Stanford Health Care
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of TermsList of Tables
Table 1. North America Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Medical Second Opinion Market, by Service Provider - Revenue and Forecast to 2027 (USD Million)
Table 3. US Medical Second Opinion Market, by Disorder - Revenue and Forecast to 2027 (USD Million)
Table 4. US Medical Second Opinion Market, by Service Provider - Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Medical Second Opinion Market, by Disorder - Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Medical Second Opinion Market, by Service Provider - Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Medical Second Opinion Market, by Disorder - Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Medical Second Opinion Market, by Service Provider - Revenue and Forecast to 2027 (USD Million)
Table 9. Europe Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 10. Europe Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 11. Germany Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 12. Germany Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 13. UK Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 14. UK Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 15. France Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 16. France Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 17. Spain Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 18. Spain Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 19. Italy Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 21. Asia Pacific Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 22. Asia Pacific Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
Table 23. China Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 24. China Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 25. Japan Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 26. Japan Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 27. India Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 28. India Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 29. South Korea Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
Table 31. Australia Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 32. Australia Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 33. Middle East & Africa Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 34. Middle East & Africa Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
Table 35. UAE Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 36. UAE Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 37. Saudi Arabia Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 38. Saudi Arabia Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
Table 39. South Africa Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 40. South Africa Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
Table 41. South and Central America Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 42. South and Central America Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027 (USD Million)
Table 43. Brazil Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 44. Brazil Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 45. Argentina Medical Second Opinion Market, by Disorders - Revenue and Forecast to 2027 (USD Million)
Table 46. Argentina Medical Second Opinion Market, by Service Providers- Revenue and Forecast to 2027(USD Million)
Table 47. Recent Inorganic Growth Strategies in the Medical Second Opinion Market
Table 48. Recent Organic Growth Strategies in The Medical Second Opinion Market
Table 49. Glossary of Terms, Medical Second Opinion Market
List of Figures
Figure 1. Medical Second Opinion Market Segmentation
Figure 2. Medical Second Opinion Market, By Region
Figure 3. Medical Second Opinion Market Overview
Figure 4. Cancer Held Largest Share of Medical Second Opinion Market in 2019
Figure 5. Medical Second Opinion Market in Asia Pacific Region to Show Remarkable Growth During Forecast Period
Figure 6. Global Medical Second Opinion Market, By Geography (US$ Million)
Figure 7. Global Medical Second Opinion Market- Leading Country Markets (US$ Million)
Figure 8. Global Medical Second Opinion Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and central America PEST Analysis
Figure 14. Medical Second Opinion Market impact analysis of driver and restraints
Figure 15. Global Medical Second Opinion Market- Revenue Forecast and Analysis - 2019- 2027
Figure 16. Global Medical Second Opinion Market- By Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning of Key Players in Global Medical Second Opinion Market
Figure 18. Medical Second Opinion Market Share, by Disorder, 2019 and 2027 (%)
Figure 19. Cancer: Medical Second Opinion Market- Revenue and Forecast to 2027 (US$ Million)
Figure 20. COPD: Medical Second Opinion Market- Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cardiac Disorders: Medical Second Opinion Market- Revenue and Forecast to 2027 (US$ Million)
Figure 22. Neurological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Nephrological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Hematological Blood Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Orthopedic Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Organ Transplant: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Other Disorders: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Medical Second Opinion Market Share, by Service Provider, 2019 and 2027 (%)
Figure 29. Hospitals Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Health Insurance Companies: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Online Services: Medical Second Opinion Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. North America: Medical Second Opinion Market, by Key Country - Revenue (2019) (USD Million)
Figure 33. North America Medical Second Opinion Market Revenue and Forecast to 2027 (USD Million)
Figure 34. North America: Medical Second Opinion Market, by Country, 2019 & 2027 (%)
Figure 35. US: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Canada: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Mexico: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: Medical Second Opinion Market, by Key Country - Revenue (2019) (USD Million)
Figure 39. Europe Medical Second Opinion Market Revenue and Forecast to 2027 (USD Million)
Figure 40. Europe: Medical Second Opinion Market, by Country, 2019 & 2027 (%)
Figure 41. Germany: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. UK: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. France: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Spain: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Italy: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 46. Asia Pacific: Medical Second Opinion Market, by Key Country - Revenue (2019) (USD Million)
Figure 47. Asia Pacific Medical Second Opinion Market Revenue and Forecast to 2027 (USD Million)
Figure 48. Asia Pacific: Medical Second Opinion Market, by Country, 2019 & 2027 (%)
Figure 49. China: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. Japan: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. India: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. South Korea: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Australia: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Middle East & Africa: Medical Second Opinion Market, by Key Country - Revenue (2019) (USD Million)
Figure 55. Middle East & Africa Medical Second Opinion Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Middle East & Africa: Medical Second Opinion Market, by Country, 2019 & 2027 (%)
Figure 57. UAE: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. South Africa: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. South and Central America: Medical Second Opinion Market, by Key Country - Revenue (2019) (USD Million)
Figure 61. South and Central America Medical Second Opinion Market Revenue and Forecast to 2027 (USD Million)
Figure 62. South and Central America: Medical Second Opinion Market, by Country, 2019 & 2027 (%)
Figure 63. Brazil: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 64. Argentina: Medical Second Opinion Market - Revenue and Forecast to 2027 (USD Million)
Figure 65. Impact of COVID-19 Pandemic in North American Country Markets
Figure 66. Impact of COVID-19 Pandemic in European Country Markets
Figure 67. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 68. Impact Of COVID-19 Pandemic in Rest of the World Countries Market
Figure 69. Growth Strategies in The Medical Second Opinion Market, 2015-2021
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medisense Healthcare Solutions Pvt. Ltd.
- Second Opinion International
- Elite Medical Services
- Cigna
- Helsana
- WorldCare
- Vidal Health Insurance TPA Pvt Ltd
- Medix
- 2nd.MD
- AXA
- Teladoc Health, Inc
- DoctorSpring Pvt. Ltd
- USARAD Holdings Inc (SecondOpinions.com)
- Cleveland Clinic
- Grand Rounds, Inc.
- Mass General Brigham Incorporated. (Partners Healthcare)
- Stanford Health Care
